Internet Information on Oral Cancer Drugs: a Critical Comparison between Website Providers.
E-health literacy
Information quality
Internet
Oral cancer drugs
Transparency
Journal
Journal of cancer education : the official journal of the American Association for Cancer Education
ISSN: 1543-0154
Titre abrégé: J Cancer Educ
Pays: England
ID NLM: 8610343
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
accepted:
23
10
2020
pubmed:
1
11
2020
medline:
26
8
2022
entrez:
31
10
2020
Statut:
ppublish
Résumé
Cancer patients need access to high-quality information, when making decisions about oral cancer drugs. The internet is often used as a source of information published by highly heterogeneous providers. The objective was to evaluate the quality of website providers supplying online information about oral cancer drugs. One hundred websites were analyzed using content-related and formal criteria, selected from three existing evaluation methods used for cancer websites, for medical information (defined by the German Agency for Quality in Medicine), and for the "fact box" tool. A web search by a patient was simulated to identify websites to evaluate. ANOVA was used to assess information provided by non-profit organizations (governmental and non-governmental), online newspapers, for-profit organizations, and private/unknown providers. Content-related quality differences were found between online newspapers and all other categories, with online newspapers ranking significantly lower than for-profit and non-profit websites. As for formal criteria, for-profit providers scored significantly lower than non-profit providers and online newspapers for the aspect of transparency. Internet information on oral cancer drugs published by non-profit organizations constitutes the best available web-based source of information for cancer patients. Health literacy and e-health literacy should be promoted in the public domain to allow patients to reliably apply web-based information. Certification should be required by law to ensure fulfillment of requirements for data reliability and transparency (authorship and funding) before health professionals recommend websites to cancer patients.
Identifiants
pubmed: 33128211
doi: 10.1007/s13187-020-01909-9
pii: 10.1007/s13187-020-01909-9
pmc: PMC9399062
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
983-993Informations de copyright
© 2020. The Author(s).
Références
Rehabilitation (Stuttg). 2017 Jun;56(3):198-213
pubmed: 28599339
Psychiatr Serv. 2009 Aug;60(8):1007
pubmed: 19648184
Soc Sci Med. 1997 Mar;44(5):681-92
pubmed: 9032835
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Oncol Res Treat. 2016;39(5):273-81
pubmed: 27173518
J Oncol Pract. 2016 Dec;12(12):1198-1202
pubmed: 27650836
BMJ. 2017 May 24;357:j2460
pubmed: 28539314
Nurs Inq. 2018 Jul;25(3):e12230
pubmed: 29327398
Patient Educ Couns. 2019 Nov;102(11):2038-2048
pubmed: 31147090
Implement Sci. 2016 Aug 08;11:114
pubmed: 27502770
Rev Saude Publica. 2015;49:4
pubmed: 25741660
Curr Oncol. 2014 Aug;21(4):165-73
pubmed: 25089098
J Cancer Res Clin Oncol. 2017 Nov;143(11):2291-2299
pubmed: 28699035
Oncol Res Treat. 2015;38(5):212-8
pubmed: 25966768
Res Social Adm Pharm. 2018 Aug;14(8):758-764
pubmed: 29066142
Z Arztl Fortbild Qualitatssich. 2005;99(6):343-51
pubmed: 16121649
JAMA Oncol. 2017 Jan 01;3(1):92-100
pubmed: 27612178
Stud Health Technol Inform. 2011;169:654-8
pubmed: 21893829